NEW YORK, Aug. 10 (GenomeWeb News) - OriGene Technologies said today that the Structural Genomics Consortium has accessed the company's TrueClone collection of over 22,000 non-redundant full-length human cDNA clones for use in its structural genomics program.
The SGC is a not-for-profit organization funded by the Wellcome Trust, GlaxoSmithKline, Genome Canada, the Ontario Research and Development Challenge Fund, the Ontario Innovation Trust, and the Canadian Institutes of Health Research. The initiative was launched in April 2003 with the goal of developing the infrastructure and technologies necessary to determine 200 protein structures per year. The SGC said it will target 350 medically significant proteins over the first four years.
"The SGC has acquired access to the OriGene collection to more rapidly extend capabilities of creating high quality protein samples for crystallization and structure determination, Michael Sundstrom, chief scientist for the SGC, said in a statement. "Access to clones from the OriGene collection combined with other sources will allow us to target the majority of genes in the first phase."